In light of recent failed trials, why would another trial by a small Canadian company be expected to succeed against the odds?
Michael Hamblin, PhD
Advertisement
Articles by Michael Hamblin, PhD
Advertisement
Latest Updated Articles
Will the Photobiomodulation Trial Be the One to Turn the Tide Against Alzheimer Disease?Published: October 24th 2019 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Patent Issued for Rapid Blood Tests to Differentiate Schizophrenia and Bipolar Disorder
2
When Symptoms Are Not Necessarily Signs of Illness: Rethinking Synchronicity in Psychiatry
3
Study Finds Semaglutide Is Associated With Improved Cognitive Function in Individuals With Psychiatric Disorders
4
International Stuttering Awareness Day: Why Psychiatrists Should Pay Attention
5
